These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9042231)

  • 1. Immunoblotting characterization of CA 125 in biological fluids: difference between pregnancy and cancer CA 125 origin.
    Barbati A; Lauro V; Orlacchio A; Cosmi EV
    Anticancer Res; 1996; 16(6B):3621-4. PubMed ID: 9042231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen.
    Jankovic MM; Tapuskovic BS
    Hum Reprod; 2005 Sep; 20(9):2632-8. PubMed ID: 15905287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids.
    Shaw JL; Grass L; Sotiropoulou G; Diamandis EP
    Clin Biochem; 2007 Jan; 40(1-2):104-10. PubMed ID: 17045982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis.
    Kurdoglu Z; Gursoy R; Kurdoglu M; Erdem M; Erdem O; Erdem A
    Fertil Steril; 2009 Nov; 92(5):1761-3. PubMed ID: 19631319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylated human prolactin: detection by immunoblotting of biological fluids is confounded by antisera crossreactivity with immunoglobulins.
    Heffner LJ; Markoff E; Yuan RW; Lee DW
    Biochem Biophys Res Commun; 1995 Jul; 212(1):48-55. PubMed ID: 7612017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity as a biological marker in some gynecological tumors: comparison with tissue and serum CA 125.
    Novakovic S; Fras PA; Jezersek-Novakovic B
    In Vivo; 2001; 15(4):327-32. PubMed ID: 11695225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells.
    Zeimet AG; Offner FA; Marth C; Heim K; Feichtinger H; Daxenbichler G; Dapunt O
    Anticancer Res; 1997; 17(4B):3129-31. PubMed ID: 9329618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane vesicles in ovarian cancer fluids: a new potential marker.
    Ginestra A; Miceli D; Dolo V; Romano FM; Vittorelli ML
    Anticancer Res; 1999; 19(4C):3439-45. PubMed ID: 10629632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate-specific antigen (PSA) in women].
    Kamenov Z; Todorova M; Khristov V
    Vutr Boles; 2001; 33(1):40-7. PubMed ID: 11785088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive proteomic analysis of human cervical-vaginal fluid.
    Dasari S; Pereira L; Reddy AP; Michaels JE; Lu X; Jacob T; Thomas A; Rodland M; Roberts CT; Gravett MG; Nagalla SR
    J Proteome Res; 2007 Apr; 6(4):1258-68. PubMed ID: 17373839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
    Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
    Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concentrations of CA 125 in uterine flushings: influence of cause of infertility and menstrual cycle day.
    Hamilton JA; Iles RK; Gunn LK; Wilson CM; Lower AM; Grudzinskas JG
    Gynecol Endocrinol; 2002 Feb; 16(1):19-25. PubMed ID: 11915577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.